{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:05:08Z","timestamp":1790413508690,"version":"4.1.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>\n                    Stem cell therapy holds significant potential for many inflammatory diseases and regenerative medicine applications. However, delivery of therapeutic cells to specific disease sites after systemic administration without indiscriminate trafficking to other non-target tissues is a major limitation of current cell therapies. Here, we describe a novel nanocarrier-directed targeted cell delivery system that enables cell surface coating with dendrimer nanocarriers containing adhesion moieties to serve as a global positioning system \u201cGPS\u201d to guide circulating cells to targeted lesions and mediate the anchoring of cells at the inflammation site. By exploiting cell surface ligands\/receptors selectively and\/or molecular moieties that are highly expressed on activated endothelium in pathologic disease states, nanocarrier-coated cells containing the counterpart binding receptors\/ligands can be enabled to specifically traffic to and dock at vasculature within target lesions. We demonstrate the efficacy of the I-domain fragment of LFA-1 (\n                    <jats:italic>id<\/jats:italic>\n                    LFA-1) complexed to modified nanocarriers to facilitate the homing of mesenchymal stem cells (MSCs) to inflamed luminal endothelial cells on which ICAM-1 is highly expressed in a murine model of aortic atherosclerosis. Our method can overcome challenges imposed by the high velocity and dynamic circulatory flow of the aorta to successfully deliver MSCs to atherosclerotic regions and allow for the docking of the potentially therapeutic and immunomodulating cells. This targeted cell delivery platform can be tailored for selective systemic delivery of various types of therapeutic cells to different disease areas.\n                  <\/jats:p>","DOI":"10.3389\/fcvm.2025.1517320","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T01:22:39Z","timestamp":1750728159000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Directing cell delivery to murine atherosclerotic aortic lesions via targeting inflamed circulatory interface using nanocarriers"],"prefix":"10.3389","volume":"12","author":[{"given":"Carlos Theodore","family":"Huerta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulexi Y.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Zeynaloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Dikici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruna J.","family":"Siahaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna K.","family":"Deo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Daunert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omaida C.","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"732742","DOI":"10.1155\/2013\/732742","article-title":"MSCs: delivery routes and engraftment, cell-targeting strategies, and immune modulation","volume":"2013","author":"Kean","year":"2013","journal-title":"Stem Cells Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3727\/096368912X636948","article-title":"No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia","volume":"21","author":"Klepanec","year":"2012","journal-title":"Cell Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1524-475X.2010.00616.x","article-title":"Promotion of cutaneous wound healing by local application of mesenchymal stem cells derived from human umbilical cord blood","volume":"18","author":"Luo","year":"2010","journal-title":"Wound Repair Regen"},{"key":"B4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-021-01037-x","article-title":"Challenges and advances in clinical applications of mesenchymal stromal cells","volume":"14","author":"Zhou","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B5","doi-asserted-by":"crossref","first-page":"e0154053","DOI":"10.1371\/journal.pone.0154053","article-title":"Directing and potentiating stem cell-mediated angiogenesis and tissue repair by cell surface E-selectin coating","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1016\/j.ymthe.2018.08.011","article-title":"PDGF restores the defective phenotype of adipose-derived mesenchymal stromal cells from diabetic patients","volume":"26","author":"Capilla-Gonz\u00e1lez","year":"2018","journal-title":"Mol Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1089\/wound.2022.0107","article-title":"Methods and limitations of augmenting mesenchymal stem cells for therapeutic applications","volume":"12","author":"Huerta","year":"2022","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jmbbm.2012.02.018","article-title":"Stiffening of human mesenchymal stem cell spheroid microenvironments induced by incorporation of gelatin microparticles","volume":"11","author":"Baraniak","year":"2012","journal-title":"J Mech Behav Biomed Mater"},{"key":"B9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/stem.2751","article-title":"Concise review: cell therapy for critical limb ischemia: an integrated review of preclinical and clinical studies","volume":"36","author":"Qadura","year":"2018","journal-title":"Stem Cells"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1113982","DOI":"10.3389\/fcvm.2023.1113982","article-title":"Mesenchymal stem cell-based therapy for non-healing wounds due to chronic limb-threatening ischemia: a review of preclinical and clinical studies","volume":"10","author":"Huerta","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1186\/ar576","article-title":"Endothelial activation: intracellular signaling pathways","volume":"4","author":"Pober","year":"2002","journal-title":"Arthritis Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1600-065X.2007.00533.x","article-title":"Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium","volume":"218","author":"Vestweber","year":"2007","journal-title":"Immunol Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics\u20142022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12889-021-10429-0","article-title":"Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017","volume":"21","author":"Amini","year":"2021","journal-title":"BMC Public Health"},{"key":"B15","article-title":"Heart Disease Facts | cdc.gov","year":"2022"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2147\/IJN.S355366","article-title":"Targeted therapy for inflammatory diseases with mesenchymal stem cells and their derived exosomes: from basic to clinics","volume":"17","author":"Wang","year":"2022","journal-title":"Int J Nanomedicine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"626755","DOI":"10.3389\/fimmu.2021.626755","article-title":"MSCs and inflammatory cells crosstalk in regenerative medicine: concerted actions for optimized resolution driven by energy metabolism","volume":"12","author":"Planat-Benard","year":"2021","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"C1442","DOI":"10.1152\/ajpcell.2001.281.5.C1442","article-title":"Essential role of ICAM-1 in mediating monocyte adhesion to aortic endothelial cells","volume":"281","author":"Kevil","year":"2001","journal-title":"Am J Physiol-Cell Physiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2013an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.1073\/pnas.97.10.5231","article-title":"NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding","volume":"97","author":"Huth","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0092-8674(02)01257-6","article-title":"Structures of the \u03b1L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation","volume":"112","author":"Shimaoka","year":"2003","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"22113","DOI":"10.1074\/jbc.273.34.22113","article-title":"Characteristics of cation binding to the I domains of LFA-1 and MAC-1. The LFA-1 I domain contains a Ca2+-binding site","volume":"273","author":"Griggs","year":"1998","journal-title":"J Biol Chem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.7150\/thno\/v01p0277","article-title":"Utilization of I-domain of LFA-1 to target drug and marker molecules to leukocytes","volume":"1","author":"Manikwar","year":"2011","journal-title":"Theranostics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0021-9150(01)00587-1","article-title":"Involvement of ICAM-1 in the progression of atherosclerosis in APOE-knockout mice","volume":"160","author":"Kitagawa","year":"2002","journal-title":"Atherosclerosis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1161\/01.ATV.18.5.842","article-title":"Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse","volume":"18","author":"Nakashima","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1161\/01.ATV.20.12.2630","article-title":"ICAM-1 Deficiency reduces atherosclerotic lesions in double-knockout mice (ApoE\u2212\/\u2212\/ICAM-1\u2212\/\u2212) fed a fat or a chow diet","volume":"20","author":"Bourdillon","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1084\/jem.191.1.189","article-title":"P-selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice","volume":"191","author":"Collins","year":"2000","journal-title":"J Exp Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1161\/01.ATV.17.8.1517","article-title":"Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice","volume":"17","author":"Nageh","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1747-0285.2007.00566.x","article-title":"ICAM-1 peptide inhibitors of T-cell adhesion bind to the allosteric site of LFA-1. An NMR characterization","volume":"70","author":"Zimmerman","year":"2007","journal-title":"Chem Biol Drug Des"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1038\/nprot.2006.202","article-title":"Using circular dichroism spectra to estimate protein secondary structure","volume":"1","author":"Greenfield","year":"2006","journal-title":"Nat Protoc"},{"key":"B32","doi-asserted-by":"publisher","first-page":"826687","DOI":"10.3389\/fcvm.2021.826687","article-title":"E-selectin-overexpressing mesenchymal stem cell therapy confers improved reperfusion, repair, and regeneration in a murine critical limb ischemia model","volume":"8","author":"Quiroz","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1128\/MCB.23.1.14-25.2003","article-title":"Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis","volume":"23","author":"Liu","year":"2003","journal-title":"Mol Cell Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1263\/jbb.99.303","article-title":"Solubilization and refolding of bacterial inclusion body proteins","volume":"99","author":"Singh","year":"2005","journal-title":"J Biosci Bioeng"},{"key":"B35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejps.2009.02.008","article-title":"ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells","volume":"37","author":"Chittasupho","year":"2009","journal-title":"Eur J Pharm Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.3390\/cimb44100320","article-title":"Western diet-fed ApoE knockout male mice as an experimental model of non-alcoholic steatohepatitis","volume":"44","author":"Camargo","year":"2022","journal-title":"Curr Issues Mol Biol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3390\/ijms22020818","article-title":"Empagliflozin attenuates non-alcoholic fatty liver disease (NAFLD) in high fat diet fed ApoE(\u2212\/\u2212) mice by activating autophagy and reducing ER stress and apoptosis","volume":"22","author":"Nasiri-Ansari","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.3389\/fimmu.2019.02852","article-title":"Therapeutic targeting of hepatic macrophages for the treatment of liver diseases","volume":"10","author":"van der Heide","year":"2019","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e22316","DOI":"10.1096\/fj.202101345RRR","article-title":"Serpina3c deficiency induced necroptosis promotes non-alcoholic fatty liver disease through \u03b2-catenin\/Foxo1\/TLR4 signaling","volume":"36","author":"Qian","year":"2022","journal-title":"FASEB J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.nucmedbio.2011.03.008","article-title":"In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis","volume":"38","author":"Gholamrezanezhad","year":"2011","journal-title":"Nucl Med Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/14653240802129893","article-title":"Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction","volume":"10","author":"Du","year":"2008","journal-title":"Cytotherapy"},{"key":"B42","doi-asserted-by":"crossref","first-page":"e0136026","DOI":"10.1371\/journal.pone.0136026","article-title":"Mesenchymal stem cells stabilize atherosclerotic vulnerable plaque by anti-inflammatory properties","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"B43","first-page":"1425","article-title":"Human amnion mesenchymal stem cells attenuate atherosclerosis by modulating macrophage function to reduce immune response","volume":"44","author":"Wei","year":"2019","journal-title":"Int J Mol Med"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1517320\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T01:22:40Z","timestamp":1750728160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1517320\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":43,"alternative-id":["10.3389\/fcvm.2025.1517320"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1517320","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.02.02.578719","asserted-by":"object"}]},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"article-number":"1517320"}}